BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21764111)

  • 1. Ovarian immature teratoma: treatment and outcome in a single institutional cohort.
    Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
    Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystectomy for immature teratoma of the ovary.
    Beiner ME; Gotlieb WH; Korach Y; Shrim A; Stockheim D; Segal Y; Fridman E; Ben-Baruch G
    Gynecol Oncol; 2004 May; 93(2):381-4. PubMed ID: 15099949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.
    Bonazzi C; Peccatori F; Colombo N; Lucchini V; Cantù MG; Mangioni C
    Obstet Gynecol; 1994 Oct; 84(4):598-604. PubMed ID: 7522313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovarian growing teratoma syndrome clinical study of 22 cases].
    Cheng NH; Huang HF; Lian LJ; Wu Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):426-30. PubMed ID: 19953942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immature teratoma of the ovary.
    Gershenson DM; del Junco G; Silva EG; Copeland LJ; Wharton JT; Rutledge FN
    Obstet Gynecol; 1986 Nov; 68(5):624-9. PubMed ID: 3763073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Tseng CJ; Chou HH; Huang KG; Chang TC; Liang CC; Lai CH; Soong YK; Hsueh S; Pao CC
    Gynecol Oncol; 1996 Dec; 63(3):364-70. PubMed ID: 8946873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature teratoma of ovary--outcome following primary and secondary surgery: study of a single institution cohort.
    Reddihalli PV; Subbian A; Umadevi K; Rathod PS; Krishnappa S; Nanaiah SP; Bafna UD
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():17-21. PubMed ID: 26142911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and prognostic factors of malignant ovarian teratoma].
    Jin FM; Zhu GZ; Feng YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive function after treatment of ovarian germ cell malignancy.
    Anita AN; Rushdan MN
    Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immature teratoma of the ovary: a clinicopathological study of 28 cases.
    Deodhar KK; Suryawanshi P; Shah M; Rekhi B; Chinoy RF
    Indian J Pathol Microbiol; 2011; 54(4):730-5. PubMed ID: 22234099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.
    Sigismondi C; Gadducci A; Lorusso D; Candiani M; Breda E; Raspagliesi F; Cormio G; Marinaccio M; Mangili G
    Gynecol Oncol; 2012 Jun; 125(3):673-6. PubMed ID: 22446621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.